期刊文献+

紫金散结汤治疗乳腺增生症的有效性与安全性研究 被引量:3

Study on the Efficacy and Safety of Using Zijin Sanjie Decoction in the Treatment of Breast Hyperplasia
下载PDF
导出
摘要 目的:观察紫金散结汤门诊治疗乳腺增生症的有效性与安全性。方法:以在2013年8月至2015年7月期间我院门诊收治的380例乳腺增生症患者作为研究对象,对其治疗资料进行回顾性分析。根据治疗方法的不同,上述患者可以分为对照组与实验组。其中实验组患者使用紫金散结汤进行治疗(n=190),而对照组患者接受乳癖散结胶囊联合逍遥丸进行治疗(n=190)。观察两组患者的治疗效果并对此进行比较。结果:相比较对照组,实验组患者各种症状评分改善更为显著,且实验组治疗有效率明显高于对照组,且该组不良反应发生率更低。统计学结果表明,上述两组间的差异均具有统计学意义(P<0.05)。结论:紫金散结汤门诊治疗乳腺增生症,症状改善明显,安全有效。因此,该方法具有在临床上进一步推广和使用的价值。 Objective: To study the efficacy and safety of outpatient treatment for breast hyperplasia by using Zijin Sanjie Decoction. Methods: 380 patients with breast hyperplasia from August 2013 to July 2015 treated in outpatient department of our hospital were considered as research objects and the data of treatment were analyzed retrospectively. According to different methods,they were divided into two groups. There were 190 patients using Zijin Sanjie Decoction for treatment in the experimental group,while there were 190 treated with Rupi Sanjie Capsule and Xiaoyao Pills in the controlled group. The treatment effects were observed and compared. Results: Compared to the controlled group,( 1) symptom scores of all the patients in the experimental group improved significantly;( 2) The effective rate of treatment in the experimental group was higher;( 3) The incidence rate of adverse reactions was lower. There was statistical significance of the differences between these two groups analyzed by statistical methods( P〈0. 05). Conclusion: Zijin Sanjie Decoction is used for outpatient treatment of breast hyperplasia,which improves symptoms significantly with more safe and effective. Therefore,this method is worth of promoting and using in clinical.
出处 《四川中医》 2016年第9期165-167,共3页 Journal of Sichuan of Traditional Chinese Medicine
关键词 紫金散结汤 乳腺增生症 有效性 安全性 Zijin Sanjie Decoction Breast hyperplasia Efficacy Safety
  • 相关文献

参考文献10

二级参考文献59

  • 1中华中医药学会外科乳腺病专业委员会.乳腺增生病诊断、辨证及疗效评价标准[S].北京:中国中医药出版社,2001:13-14.
  • 2Putti TC, Pinder SE, Elston CW, et al. Breast pathology practiee: most common problems in a consultation service [ J ]. Histopathology, 2005,47 (5) : 445 - 457.
  • 3Fernandez-Valdivia R, Mukherjee A, Mulae-Jericevie B, et al. Revealing progesterone, s role in uterine and mammary gland biology: insights from the mouse[J ]. Senain Reprod Med,2005,23(1) :22 - 37.
  • 4Fentiman IS,Caleffi M, Brame K, et al. Double-blind controlled trial of tamoxifen therapy for mastalgia[J ]. Lancet, 1986,1 (8476) : 287 - 288.
  • 5Fisher B,Costantino JP,Wickerham DL,et al Tamoxifen for prevention of breast cancer:report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancel Inst, 1998,90 (18):1371.
  • 6德铭.实用中医乳房病学[M].上海:上海中医学院出版社,1993.127,122.
  • 7王庆,丰晓霞,陈光虎,姜霞.不同剂量米非司酮治疗乳腺增生症对比分析[J].现代预防医学,2007,34(16):3186-3187. 被引量:4
  • 8李兆亭 阮长乐.实用普通外科[M].济南:山东科学出版社,2001.102-102.
  • 9吴在德 吴肇汉.外科学(第6版)[M].北京:人民卫生出版社,2003.568-573.
  • 10林毅,唐汉钧.现代中医乳房病学[M].北京:人民卫生出版社,1998.741—754.

共引文献93

同被引文献29

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部